Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways | |
Zhou, Feng; Zhang, Ying; Chen, Jing; Hu, Yimeng; Xu, Yancheng | |
刊名 | FRONTIERS IN ENDOCRINOLOGY
![]() |
2018 | |
卷号 | 9 |
关键词 | hepatic metaflammation NLRP3 inflammasome non-alcoholic fatty liver disease verapamil thioredoxin-interacting protein(TXNIP) |
ISSN号 | 1664-2392 |
DOI | 10.3389/fendo.2018.00640 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4140367 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Zhou, Feng,Zhang, Ying,Chen, Jing,et al. Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways[J]. FRONTIERS IN ENDOCRINOLOGY,2018,9. |
APA | Zhou, Feng,Zhang, Ying,Chen, Jing,Hu, Yimeng,&Xu, Yancheng.(2018).Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways.FRONTIERS IN ENDOCRINOLOGY,9. |
MLA | Zhou, Feng,et al."Verapamil Ameliorates Hepatic Metaflammation by Inhibiting Thioredoxin-Interacting Protein/NLRP3 Pathways".FRONTIERS IN ENDOCRINOLOGY 9(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论